CIK 0001119774
- Accelerated filer
COMPUGEN LTD
Sign in to watch- Ticker
- CGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Other
- Phone
- +972 37658585
- Business address
- 26 HAROKMIM STREET, BUILDING D, HOLON, Israel, 5885849
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-29 | Ophir Eran President and CEO | Grant or award · Share Option (right to buy) | +200,000 | 200,000 | ||
| 2026-04-24 | Ophir Eran President and CEO | Exercise or conversion 10b5-1 | +5,000 | $0.83 | $4K | 16,375 |
| 2026-04-24 | Ophir Eran President and CEO | Sale 10b5-1 | −5,000 | $3.20 | $16K | 11,375 |
| 2026-04-24 | Ophir Eran President and CEO | Exercise or conversion · Share Option (right to buy) 10b5-1 | −5,000 | 14,375 | ||
| 2026-04-14 | Ophir Eran President and CEO | Exercise or conversion 10b5-1 | +5,000 | $0.83 | $4K | 16,375 |
| 2026-04-14 | Ophir Eran President and CEO | Sale 10b5-1 | −5,000 | $2.90 | $15K | 11,375 |
| 2026-04-14 | Ophir Eran President and CEO | Exercise or conversion · Share Option (right to buy) 10b5-1 | −5,000 | 19,375 | ||
| 2026-04-01 | Ophir Eran President and CEO | Exercise or conversion 10b5-1 | +5,625 | $0.83 | $5K | 17,000 |
| 2026-04-01 | Ophir Eran President and CEO | Sale 10b5-1 | −5,625 | $2.21 | $12K | 11,375 |
| 2026-04-01 | Ophir Eran President and CEO | Exercise or conversion · Share Option (right to buy) 10b5-1 | −5,625 | 24,375 |
Page 1 of 1 · 10 trades